Macular edema due to diabetes mellitus

Unitys eye treatment fails to match Eylea, though analysts still see a path forward

1 month ago talkbio0Tagged analysts, Eylea, Macular edema due to diabetes mellitus, match Eylea

analysts, Eylea, match Eylea, Macular edema due to diabetes mellitus

FDA Approves Roche’s Susvimo for Diabetic Macular Edema: A Breakthrough in Continuous Delivery Eye Treatment

3 months ago talkbio0Tagged Approved, Continuous Delivery, dimethylethylsilylimidazole, Macular edema due to diabetes mellitus, Ophthalmological implant, ranibizumab, Roche (company), Susvimo, United States Food and Drug Administration, Vision

Susvimo, ranibizumab, diabetic macular edema, DME, Roche, FDA approval, continuous delivery, eye implant, vision improvement

Aviceda Secures $200M Series C Funding to Advance Ocular Drug AVD-104 into Late-Stage Trials

4 months ago talkbio0Tagged Age related macular degeneration, AVD-104, Genus Aviceda, Geographic Atrophy, late-stage clinical trials, Macular edema due to diabetes mellitus, Series C

Aviceda Therapeutics, AVD-104, Geographic Atrophy, Age-Related Macular Degeneration, Diabetic Macular Edema, Series C Funding, Late-Stage Clinical Trials

Vabysmo’s Growth Pace Slows in Q3, Still on Track for Dominance in Eye Disease Market

6 months ago talkbio0Tagged Age related macular degeneration, Macular edema due to diabetes mellitus, Market, Regeneron, Roche (company), Vabysmo, Vascular Endothelial Growth Factor A

Vabysmo, Roche, Regeneron, Eylea HD, eye disease market, vascular endothelial growth factor A (VEGF-A) therapy, age-related macular degeneration (AMD), diabetic macular edema (DME).